0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fluorinated Pharmaceutical Intermediates Market Insights, Forecast to 2028
Published Date: November 2022
|
Report Code: QYRE-Auto-18A12300
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Fluorinated Pharmaceutical Intermediates Market Research Report 2022
BUY CHAPTERS

Global Fluorinated Pharmaceutical Intermediates Market Insights, Forecast to 2028

Code: QYRE-Auto-18A12300
Report
November 2022
Pages:117
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Fluorinated Pharmaceutical Intermediates estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Fluorinated Pharmaceutical Intermediates is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Fluorinated Pharmaceutical Intermediates is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Fluorinated Pharmaceutical Intermediates is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Fluorinated Pharmaceutical Intermediates include Lonza, Catalent, Patheon, BASF, Jubilant, Granules, Ganesh, Chemcon and Chemours, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Fluorinated Pharmaceutical Intermediates companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Fluorinated Pharmaceutical Intermediates market. Further, it explains the major drivers and regional dynamics of the global Fluorinated Pharmaceutical Intermediates market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Lonza
Catalent
Patheon
BASF
Jubilant
Granules
Ganesh
Chemcon
Chemours
Zhejiang Yongtai Technology
Shenzhen Capchem Technology
Zhejiang Zhongxin Fluoride Materials
Jiangsu Feiyu Technology
Shanghai Sinofluoro
Shanghai Aqbiopharma
Hangzhou Fluoro Pharmaceutical
Zhejiang Dayang Biotech
Shandong Feiyuan Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Fluorinated Pharmaceutical Intermediates Segment by Type

Aromatic Fluoride
Aliphatic Fluoride

Fluorinated Pharmaceutical Intermediates Segment by Application

Antiviral Drug
Anti-infectives Drug
Antirheumatic Drug
Antibacterial Drug
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Fluorinated Pharmaceutical Intermediates market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Fluorinated Pharmaceutical Intermediates market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Fluorinated Pharmaceutical Intermediates, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fluorinated Pharmaceutical Intermediates, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fluorinated Pharmaceutical Intermediates revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Fluorinated Pharmaceutical Intermediates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Fluorinated Pharmaceutical Intermediates revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lonza, Catalent, Patheon, BASF, Jubilant, Granules, Ganesh, Chemcon and Chemours, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fluorinated Pharmaceutical Intermediates in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fluorinated Pharmaceutical Intermediates companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fluorinated Pharmaceutical Intermediates revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aromatic Fluoride
1.2.3 Aliphatic Fluoride
1.3 Market by Application
1.3.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Antiviral Drug
1.3.3 Anti-infectives Drug
1.3.4 Antirheumatic Drug
1.3.5 Antibacterial Drug
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fluorinated Pharmaceutical Intermediates Market Perspective (2017-2028)
2.2 Fluorinated Pharmaceutical Intermediates Growth Trends by Region
2.2.1 Fluorinated Pharmaceutical Intermediates Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fluorinated Pharmaceutical Intermediates Historic Market Size by Region (2017-2022)
2.2.3 Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2023-2028)
2.3 Fluorinated Pharmaceutical Intermediates Market Dynamics
2.3.1 Fluorinated Pharmaceutical Intermediates Industry Trends
2.3.2 Fluorinated Pharmaceutical Intermediates Market Drivers
2.3.3 Fluorinated Pharmaceutical Intermediates Market Challenges
2.3.4 Fluorinated Pharmaceutical Intermediates Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue
3.1.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue (2017-2022)
3.1.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Players (2017-2022)
3.2 Global Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fluorinated Pharmaceutical Intermediates Revenue
3.4 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio
3.4.1 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluorinated Pharmaceutical Intermediates Revenue in 2021
3.5 Fluorinated Pharmaceutical Intermediates Key Players Head office and Area Served
3.6 Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
3.7 Date of Enter into Fluorinated Pharmaceutical Intermediates Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fluorinated Pharmaceutical Intermediates Breakdown Data by Type
4.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Type (2017-2022)
4.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2023-2028)
5 Fluorinated Pharmaceutical Intermediates Breakdown Data by Application
5.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Application (2017-2022)
5.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
6.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Type
6.2.1 North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
6.2.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
6.2.3 North America Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Application
6.3.1 North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
6.3.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
6.3.3 North America Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
6.4 North America Fluorinated Pharmaceutical Intermediates Market Size by Country
6.4.1 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
6.4.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
7.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Type
7.2.1 Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
7.2.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
7.2.3 Europe Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Application
7.3.1 Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
7.3.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
7.3.3 Europe Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
7.4 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country
7.4.1 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
7.4.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type
8.2.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application
8.3.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
8.4 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region
8.4.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
9.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type
9.2.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
9.2.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
9.2.3 Latin America Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
9.3 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application
9.3.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
9.3.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
9.3.3 Latin America Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
9.4 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country
9.4.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
9.4.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Type
10.2.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Share by Type (2017-2028)
10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Application
10.3.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Share by Application (2017-2028)
10.4 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country
10.4.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Fluorinated Pharmaceutical Intermediates Introduction
11.1.4 Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.1.5 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Fluorinated Pharmaceutical Intermediates Introduction
11.2.4 Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.2.5 Catalent Recent Developments
11.3 Patheon
11.3.1 Patheon Company Details
11.3.2 Patheon Business Overview
11.3.3 Patheon Fluorinated Pharmaceutical Intermediates Introduction
11.3.4 Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.3.5 Patheon Recent Developments
11.4 BASF
11.4.1 BASF Company Details
11.4.2 BASF Business Overview
11.4.3 BASF Fluorinated Pharmaceutical Intermediates Introduction
11.4.4 BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.4.5 BASF Recent Developments
11.5 Jubilant
11.5.1 Jubilant Company Details
11.5.2 Jubilant Business Overview
11.5.3 Jubilant Fluorinated Pharmaceutical Intermediates Introduction
11.5.4 Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.5.5 Jubilant Recent Developments
11.6 Granules
11.6.1 Granules Company Details
11.6.2 Granules Business Overview
11.6.3 Granules Fluorinated Pharmaceutical Intermediates Introduction
11.6.4 Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.6.5 Granules Recent Developments
11.7 Ganesh
11.7.1 Ganesh Company Details
11.7.2 Ganesh Business Overview
11.7.3 Ganesh Fluorinated Pharmaceutical Intermediates Introduction
11.7.4 Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.7.5 Ganesh Recent Developments
11.8 Chemcon
11.8.1 Chemcon Company Details
11.8.2 Chemcon Business Overview
11.8.3 Chemcon Fluorinated Pharmaceutical Intermediates Introduction
11.8.4 Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.8.5 Chemcon Recent Developments
11.9 Chemours
11.9.1 Chemours Company Details
11.9.2 Chemours Business Overview
11.9.3 Chemours Fluorinated Pharmaceutical Intermediates Introduction
11.9.4 Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.9.5 Chemours Recent Developments
11.10 Zhejiang Yongtai Technology
11.10.1 Zhejiang Yongtai Technology Company Details
11.10.2 Zhejiang Yongtai Technology Business Overview
11.10.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Introduction
11.10.4 Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.10.5 Zhejiang Yongtai Technology Recent Developments
11.11 Shenzhen Capchem Technology
11.11.1 Shenzhen Capchem Technology Company Details
11.11.2 Shenzhen Capchem Technology Business Overview
11.11.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Introduction
11.11.4 Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.11.5 Shenzhen Capchem Technology Recent Developments
11.12 Zhejiang Zhongxin Fluoride Materials
11.12.1 Zhejiang Zhongxin Fluoride Materials Company Details
11.12.2 Zhejiang Zhongxin Fluoride Materials Business Overview
11.12.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Introduction
11.12.4 Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.12.5 Zhejiang Zhongxin Fluoride Materials Recent Developments
11.13 Jiangsu Feiyu Technology
11.13.1 Jiangsu Feiyu Technology Company Details
11.13.2 Jiangsu Feiyu Technology Business Overview
11.13.3 Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Introduction
11.13.4 Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.13.5 Jiangsu Feiyu Technology Recent Developments
11.14 Shanghai Sinofluoro
11.14.1 Shanghai Sinofluoro Company Details
11.14.2 Shanghai Sinofluoro Business Overview
11.14.3 Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Introduction
11.14.4 Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.14.5 Shanghai Sinofluoro Recent Developments
11.15 Shanghai Aqbiopharma
11.15.1 Shanghai Aqbiopharma Company Details
11.15.2 Shanghai Aqbiopharma Business Overview
11.15.3 Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Introduction
11.15.4 Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.15.5 Shanghai Aqbiopharma Recent Developments
11.16 Hangzhou Fluoro Pharmaceutical
11.16.1 Hangzhou Fluoro Pharmaceutical Company Details
11.16.2 Hangzhou Fluoro Pharmaceutical Business Overview
11.16.3 Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Introduction
11.16.4 Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.16.5 Hangzhou Fluoro Pharmaceutical Recent Developments
11.17 Zhejiang Dayang Biotech
11.17.1 Zhejiang Dayang Biotech Company Details
11.17.2 Zhejiang Dayang Biotech Business Overview
11.17.3 Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Introduction
11.17.4 Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.17.5 Zhejiang Dayang Biotech Recent Developments
11.18 Shandong Feiyuan Group
11.18.1 Shandong Feiyuan Group Company Details
11.18.2 Shandong Feiyuan Group Business Overview
11.18.3 Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Introduction
11.18.4 Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
11.18.5 Shandong Feiyuan Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Aromatic Fluoride
    Table 3. Key Players of Aliphatic Fluoride
    Table 4. Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2017-2022)
    Table 8. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2023-2028)
    Table 10. Fluorinated Pharmaceutical Intermediates Market Trends
    Table 11. Fluorinated Pharmaceutical Intermediates Market Drivers
    Table 12. Fluorinated Pharmaceutical Intermediates Market Challenges
    Table 13. Fluorinated Pharmaceutical Intermediates Market Restraints
    Table 14. Global Fluorinated Pharmaceutical Intermediates Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Players (2017-2022)
    Table 16. Global Top Fluorinated Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2021)
    Table 17. Ranking of Global Top Fluorinated Pharmaceutical Intermediates Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
    Table 21. Date of Enter into Fluorinated Pharmaceutical Intermediates Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2017-2022)
    Table 25. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2023-2028)
    Table 27. Global Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Application (2017-2022)
    Table 29. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Application (2023-2028)
    Table 31. North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Lonza Company Details
    Table 62. Lonza Business Overview
    Table 63. Lonza Fluorinated Pharmaceutical Intermediates Product
    Table 64. Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 65. Lonza Recent Developments
    Table 66. Catalent Company Details
    Table 67. Catalent Business Overview
    Table 68. Catalent Fluorinated Pharmaceutical Intermediates Product
    Table 69. Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 70. Catalent Recent Developments
    Table 71. Patheon Company Details
    Table 72. Patheon Business Overview
    Table 73. Patheon Fluorinated Pharmaceutical Intermediates Product
    Table 74. Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 75. Patheon Recent Developments
    Table 76. BASF Company Details
    Table 77. BASF Business Overview
    Table 78. BASF Fluorinated Pharmaceutical Intermediates Product
    Table 79. BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 80. BASF Recent Developments
    Table 81. Jubilant Company Details
    Table 82. Jubilant Business Overview
    Table 83. Jubilant Fluorinated Pharmaceutical Intermediates Product
    Table 84. Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 85. Jubilant Recent Developments
    Table 86. Granules Company Details
    Table 87. Granules Business Overview
    Table 88. Granules Fluorinated Pharmaceutical Intermediates Product
    Table 89. Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 90. Granules Recent Developments
    Table 91. Ganesh Company Details
    Table 92. Ganesh Business Overview
    Table 93. Ganesh Fluorinated Pharmaceutical Intermediates Product
    Table 94. Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 95. Ganesh Recent Developments
    Table 96. Chemcon Company Details
    Table 97. Chemcon Business Overview
    Table 98. Chemcon Fluorinated Pharmaceutical Intermediates Product
    Table 99. Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 100. Chemcon Recent Developments
    Table 101. Chemours Company Details
    Table 102. Chemours Business Overview
    Table 103. Chemours Fluorinated Pharmaceutical Intermediates Product
    Table 104. Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 105. Chemours Recent Developments
    Table 106. Zhejiang Yongtai Technology Company Details
    Table 107. Zhejiang Yongtai Technology Business Overview
    Table 108. Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Product
    Table 109. Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 110. Zhejiang Yongtai Technology Recent Developments
    Table 111. Shenzhen Capchem Technology Company Details
    Table 112. Shenzhen Capchem Technology Business Overview
    Table 113. Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Product
    Table 114. Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 115. Shenzhen Capchem Technology Recent Developments
    Table 116. Zhejiang Zhongxin Fluoride Materials Company Details
    Table 117. Zhejiang Zhongxin Fluoride Materials Business Overview
    Table 118. Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Product
    Table 119. Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 120. Zhejiang Zhongxin Fluoride Materials Recent Developments
    Table 121. Jiangsu Feiyu Technology Company Details
    Table 122. Jiangsu Feiyu Technology Business Overview
    Table 123. Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Product
    Table 124. Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 125. Jiangsu Feiyu Technology Recent Developments
    Table 126. Shanghai Sinofluoro Company Details
    Table 127. Shanghai Sinofluoro Business Overview
    Table 128. Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Product
    Table 129. Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 130. Shanghai Sinofluoro Recent Developments
    Table 131. Shanghai Aqbiopharma Company Details
    Table 132. Shanghai Aqbiopharma Business Overview
    Table 133. Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Product
    Table 134. Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 135. Shanghai Aqbiopharma Recent Developments
    Table 136. Hangzhou Fluoro Pharmaceutical Company Details
    Table 137. Hangzhou Fluoro Pharmaceutical Business Overview
    Table 138. Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Product
    Table 139. Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 140. Hangzhou Fluoro Pharmaceutical Recent Developments
    Table 141. Zhejiang Dayang Biotech Company Details
    Table 142. Zhejiang Dayang Biotech Business Overview
    Table 143. Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Product
    Table 144. Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 145. Zhejiang Dayang Biotech Recent Developments
    Table 146. Shandong Feiyuan Group Company Details
    Table 147. Shandong Feiyuan Group Business Overview
    Table 148. Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Product
    Table 149. Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022) & (US$ Million)
    Table 150. Shandong Feiyuan Group Recent Developments
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fluorinated Pharmaceutical Intermediates Market Share by Type: 2021 VS 2028
    Figure 2. Aromatic Fluoride Features
    Figure 3. Aliphatic Fluoride Features
    Figure 4. Global Fluorinated Pharmaceutical Intermediates Market Share by Application: 2021 VS 2028
    Figure 5. Antiviral Drug Case Studies
    Figure 6. Anti-infectives Drug Case Studies
    Figure 7. Antirheumatic Drug Case Studies
    Figure 8. Antibacterial Drug Case Studies
    Figure 9. Others Case Studies
    Figure 10. Fluorinated Pharmaceutical Intermediates Report Years Considered
    Figure 11. Global Fluorinated Pharmaceutical Intermediates Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Fluorinated Pharmaceutical Intermediates Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Fluorinated Pharmaceutical Intermediates Market Share by Region: 2021 VS 2028
    Figure 14. Global Fluorinated Pharmaceutical Intermediates Market Share by Players in 2021
    Figure 15. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue in 2021
    Figure 17. North America Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
    Figure 19. North America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
    Figure 20. North America Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
    Figure 21. United States Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
    Figure 27. Germany Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Fluorinated Pharmaceutical Intermediates Market Size Share by Region (2017-2028)
    Figure 37. China Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
    Figure 47. Mexico Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size Share by Country (2017-2028)
    Figure 53. Turkey Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Lonza Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 57. Catalent Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 58. Patheon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 59. BASF Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 60. Jubilant Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 61. Granules Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 62. Ganesh Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 63. Chemcon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 64. Chemours Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 65. Zhejiang Yongtai Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 66. Shenzhen Capchem Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 67. Zhejiang Zhongxin Fluoride Materials Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 68. Jiangsu Feiyu Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 69. Shanghai Sinofluoro Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 70. Shanghai Aqbiopharma Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 71. Hangzhou Fluoro Pharmaceutical Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 72. Zhejiang Dayang Biotech Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 73. Shandong Feiyuan Group Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS